Anti-hormonal Therapie With or Without Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

Condition:   Breast Cancer Metastatic Interventions:   Drug: Ribociclib;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Tamoxifen Sponsor:   German Breast Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials